The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis.

Arnaiz JA, Rodrigues-Silva C, Mezquida G, Amoretti S, Cuesta MJ, Fraguas D, Lobo A, González-Pinto A, Díaz-Caneja MC, Corripio I, Vieta E, Baeza I, Mané A, García-Rizo C, Bioque M, Saiz J, Bernardo M, Mas S, PEPs group

Open source

DOI
10.1007/s00213-020-05715-5
Published
2021 Mar
Container
Psychopharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00213-020-05715-5,
  title = {The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis.},
  author = {Arnaiz JA and Rodrigues-Silva C and Mezquida G and Amoretti S and Cuesta MJ and Fraguas D and Lobo A and González-Pinto A and Díaz-Caneja MC and Corripio I and Vieta E and Baeza I and Mané A and García-Rizo C and Bioque M and Saiz J and Bernardo M and Mas S and PEPs group},
  year = {2021},
  journal = {Psychopharmacology},
  doi = {10.1007/s00213-020-05715-5},
  url = {https://doi.org/10.1007/s00213-020-05715-5}
}

RIS

TY  - JOUR
TI  - The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis.
AU  - Arnaiz JA
AU  - Rodrigues-Silva C
AU  - Mezquida G
AU  - Amoretti S
AU  - Cuesta MJ
AU  - Fraguas D
AU  - Lobo A
AU  - González-Pinto A
AU  - Díaz-Caneja MC
AU  - Corripio I
AU  - Vieta E
AU  - Baeza I
AU  - Mané A
AU  - García-Rizo C
AU  - Bioque M
AU  - Saiz J
AU  - Bernardo M
AU  - Mas S
AU  - PEPs group
PY  - 2021
JO  - Psychopharmacology
DO  - 10.1007/s00213-020-05715-5
UR  - https://doi.org/10.1007/s00213-020-05715-5
ER  - 

APA

JA, A., C, R., G, M., S, A., MJ, C., D, F., A, L., A, G., MC, D., I, C., E, V., I, B., A, M., C, G., M, B., J, S., M, B., S, M., & group, P. (2021). The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis.. Psychopharmacology. https://doi.org/10.1007/s00213-020-05715-5

Source records